JPRN-jRCTs031210249进行中（未招募）1 期
Efficacy and safety of [11C]NCGG401 as a PET imaging ligand for microglia in the brain
Kimura Yasuyuki0 个研究点目标入组 9 人开始时间: 2021年8月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 40age old（—）
- 性别
- Male
入选标准
- •1) Males who are between 20 and 40 years old at the time of consent.
- •2) A person who voluntarily applies for the study and is judged by the principal investigator or sub-investigator to be able to understand the contents of the explanatory document.
排除标准
- •1) Patients with obvious abnormality in the clinical examination conducted after obtaining consent.
- •2) Patients whose head MRI scan revealed findings that are suspected to affect the PET scan (such as a clear history of cerebral infarction or cerebral hemorrhage).
- •3)Those whose cognitive or intellectual functioning is below the normal range on psychological testing, and those whose developmental or mental status is considered to interfere with testing (Step 2 only).
- •4) Those who have magnetic metals in their body (tattoos, tattoos including art makeup, pacemakers, etc.).
- •5) Those who are highly claustrophobic.
- •6) Those who have a history of drug allergy.
- •7) Those who have serious complications or those who have a history of such complications and are judged by the principal investigator or sub-investigator to be ineligible for this study.
- •8) Subjects who are regularly taking steroidal or non-steroidal anti-inflammatory drugs.
- •9) Those who have participated in other clinical research involving intervention for less than one year from the time of obtaining consent.
- •10) Those who have participated in nuclear medicine examinations of other healthy volunteers for less than 6 months from the time of obtaining consent, in view of radiation exposure in nuclear medicine examinations.
- •11) Those who have not consented to the storage of specimens in our biobank.
- •12) Any other person who is judged by the principal investigator or sub-investigator to be ineligible as a subject of this study.
研究者
相似试验
招募中
2 期
CGG401-ADAlzheimer's diseaseTemporal lobe epilepsyGliomaJPRN-jRCTs031230338Kimura Yasuyuki55
进行中（未招募）
1 期
Safety and efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophila BHaemophilia BMedDRA version: 20.0Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2012-004867-38-ITOVO NORDISK. S.P.A.50
已完成
1 期
Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.Healthy VolunteersNCT05285696Cytosite Biopharma Inc.6
招募中
不适用
Safety and clinical performance of the GEM-power Cable system in adult spinal deformity surgery: A first in human clinical investigatioNL-OMON29150MaastrichtUMC+14
招募中
不适用
Investigation of the clinical usefulness of next generation optical coherence tomographyretinal diseasesJPRN-UMIN000029391Tokyo Medical and Dental University hospital500